FINWIRES · TerminalLIVE
FINWIRES

Takachiho Koheki to Extend Takeover Defense Measures Until 2028

By

Takachiho Koheki (TYO:2676) will continue its takeover response measures against large-scale share purchases until June 2028, subject to shareholder approval at its annual general meeting in June, according to a Friday filing on the Tokyo Stock Exchange.

The plan applies to acquisitions that would result in an investor group holding 20% or more of voting rights, unless approved in advance by the board, the electronics technology trading company said.

The policy is intended to protect corporate value and shareholder interests by giving the board and shareholders sufficient time and information to assess large-scale acquisition proposals.

Takachiho Koheki said there are no changes to the content of the existing plan apart from updates tied to organizational changes and timelines. It also said it has not received any proposal for a large-scale acquisition of its shares.

Under the policy, the board may take countermeasures, including issuing stock acquisition rights, if a bidder does not comply with the company's review procedures or if a proposed acquisition could materially harm shareholder interests.

Related Articles

Asia

Hengrui Pharma Gets China Approval for Lymphoma Drug Trial

Jiangsu Hengrui Pharmaceuticals (SHA:600276) unit Suzhou Sundia Biopharmaceuticals obtained the approval of China's drug regulator to begin clinical trials for SHR-3079 injection.The drug is indicated to treat B-cell non-Hodgkin's lymphoma, according to a Thursday filing with the Shanghai bourse.Shares of the pharmaceutical company were down 1% Friday.

$SHA:600276
Asia

Hengrui Pharma Gets China Nod for Atopic Dermatitis Drug Trial

Jiangsu Hengrui Pharmaceuticals (SHA:600276) unit Ruishi Biopharmaceuticals obtained the approval of China's drug regulator to begin clinical trials for RSS0393 Latex.The drug is indicated to treat atopic dermatitis, according to a Friday filing with the Shanghai bourse.Shares of the pharmaceutical company were down 1% Friday.

$SHA:600276
Asia

Endurance Technologies' Consolidated Profit Rises in Fiscal Q4; Shares Plummet 5%

Endurance Technologies' (NSE:ENDURANCE, BOM:540153) consolidated profit attributable to the owners increased to 2.76 billion Indian rupees in the fiscal fourth quarter from 2.45 billion rupees a year ago, according to a Thursday filing to the Indian stock exchanges.Shares of the company fell over 5% in Friday's trade.Earnings per share for the quarter ended March 31 climbed to 19.65 rupees from 17.43 rupees a year earlier.Revenue from operations of the aluminum die-casting company jumped year on year to 40.9 billion rupees from 29.6 billion rupees, the filing said.The board of Endurance Technologies declared a dividend of 11.50 rupees per share for the fiscal year ended March 31.

$BOM:540153$NSE:ENDURANCE